Insider Transactions
Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 28, 2022 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,781 | $0.25 | 144,795 |
Feb 12, 2021 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,533 | $0.25 | 136,014 |
Feb 02, 2021 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,152 | $0.25 | 132,481 |
Jan 29, 2021 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,991 | $0.25 | 120,329 |
Jan 15, 2021 |
EVP and CFO
|
EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 809 | $95.15 | 11,333 |
Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,749 | $100.77 | 19,891 |
Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,588 | $98.46 | 28,479 |
Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 16,337 | $137.33 | 12,142 |
Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,749 | -- | -- |
Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,588 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.